RXN - Rexnord Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-03-30
2018-03-30
2017-03-30
2016-03-30
Total Revenue
2,052,100
2,050,900
2,066,000
1,918,200
1,923,800
Cost of Revenue
1,256,200
1,266,100
1,309,100
1,250,200
1,258,600
Gross Profit
795,900
784,800
756,900
668,000
665,200
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
430,000
433,100
446,200
410,600
398,600
Total Operating Expenses
464,500
467,100
479,800
452,700
456,000
Operating Income or Loss
331,400
317,700
277,100
215,300
209,200
Interest Expense
-
69,900
75,600
88,700
91,400
Total Other Income/Expenses Net
-7,800
-9,000
-145,000
-44,600
-31,800
Income Before Tax
260,200
238,800
56,500
82,000
86,000
Income Tax Expense
56,000
53,400
-19,500
7,900
17,100
Income from Continuing Operations
205,800
189,000
76,000
74,100
68,900
Net Income
175,700
34,300
75,900
74,100
67,900
Net Income available to common shareholders
152,500
11,100
52,700
66,800
67,900
Reported EPS
Basic
-
0.10
0.51
0.65
0.67
Diluted
-
0.10
0.50
0.64
0.66
Weighted average shares outstanding
Basic
-
104,640
103,889
102,753
100,841
Diluted
-
123,329
105,999
104,784
103,310
EBITDA
-
410,000
366,800
320,700
324,600